Molecular neuroendocrine targets for obesity therapy

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 17, Issue 5, 2010, Pages 441-445

  De Kloet, Annette D ^a   Woods, Stephen C ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

energy balance; food intake; metabolism; neuroendocrine; obesity

Indexed keywords

CHOLECYSTOKININ; GHRELIN; GLUCAGON LIKE PEPTIDE;

ENERGY BALANCE; FOOD INTAKE; HUMAN; NEUROENDOCRINE SYSTEM; NONHUMAN; OBESITY; PROTEIN EXPRESSION; REVIEW; SATIETY; WEIGHT REDUCTION;

ADIPOSE TISSUE; ANIMALS; APPETITE REGULATION; CHOLECYSTOKININ; ENERGY INTAKE; GASTROINTESTINAL TRACT; GHRELIN; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INSULIN; LEPTIN; MICE; NEUROSECRETORY SYSTEMS; OBESITY; WEIGHT LOSS;

EID: 77956268385     PISSN: 1752296X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MED.0b013e32833c3013     Document Type: Review

References (60)

1. Schwartz MW, Woods SC, Porte D, et al. Central nervous system control of food intake. Nature 2000; 404:661-671.
2. Woods SC, Seeley RJ, Porte D Jr, Schwartz MW. Signals that regulate food intake and energy homeostasis. Science 1998; 280:1378-1383.
3. Tamashiro KL, Terrillion CE, Hyun J, et al. Prenatal stress or high-fat diet increases susceptibility to diet-induced obesity in rat offspring. Diabetes 2009; 58:1116-1125.
4. Woods SC. The control of food intake: behavioral versus molecular perspectives. Cell Metab 2009; 9:489-498.
5. Raybould HE. Gut chemosensing: interactions between gut endocrine cells and visceral afferents. Auton Neurosci 2010; 153 (1-2):41-46.
6. Moran TH, Kinzig KP. Gastrointestinal satiety signals II. cholecystokinin. Am J Physiol Gastrointest Liver Physiol 2004; 286:G183-G188.
7. Polak JM, Bloom SR, Rayford PL, et al. Identification of cholecystokinin-secreting cells. Lancet 1975; 2:1016-1018.
8. West DB, Fey D, Woods SC. Cholecystokinin persistently suppresses meal size but not food intake in free-feeding rats. Am J Physiol 1984; 246 (5 Pt 2): R776-R787.
9. Moran TH, Ameglio PJ, Peyton HJ, et al. Blockade of type A, but not type B, CCK receptors postpones satiety in rhesus monkeys. Am J Physiol 1993; 265 (3 Pt 2):R620-R624.
10. Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351:2683-2693.
11. Crawley JN, Beinfeld MC. Rapid development of tolerance to the behavioural actions of cholecystokinin. Nature 1983; 302:703-706.
12. Duncan EA, Davita G, Woods SC. Changes in the satiating effect of cholecystokinin over repeated trials. Physiol Behav 2005; 85:387-393.
13. Moran TH, Sawyer TK, Seeb DH, et al. Potent and sustained satiety actions of a cholecystokinin octapeptide analogue. Am J Clin Nutr 1992; 55 (1 Suppl): 286S-290S.
14. Jordan J, Greenway FL, Leiter LA, et al. Stimulation of cholecystokinin-A receptors with GI181771X does not cause weight loss in overweight or obese patients. Clin Pharmacol Ther 2008; 83:281-287.
15. Lo CM, King A, Samuelson LC, et al. Cholecystokinin knockout mice are resistant to high-fat diet-induced obesity. Gastroenterology 2010; 138:1997-2005.
16. Varndell IM, Bishop AE, Sikri KL, et al. Localization of glucagon-like peptide (GLP) immunoreactants in human gut and pancreas using light and electron microscopic immunocytochemistry. J Histochem Cytochem 1985; 33:1080-1086.
17. Merchenthaler I, Lane M, Shughrue P. Distribution of prepro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system. J Comp Neurol 1999; 403:261-280.
18. Williams DL. Minireview: finding the sweet spot: peripheral versus central glucagon-like peptide 1 action in feeding and glucose homeostasis. Endocrinology 2009; 150:2997-3001.
19. Scott KA, Moran TH. The GLP-1 agonist exendin-4 reduces food intake in nonhuman primates through changes in meal size. Am J Physiol Regul Integr Comp Physiol 2007; 293:R983-R987.
20. Barrera JG, D'Alessio DA, Drucker DJ, et al. Differences in the central anorectic effects of glucagon-like peptide-1 and exendin-4 in rats. Diabetes 2009; 58:2820-2827.
21. Williams DL, Baskin DG, Schwartz MW. Evidence that intestinal glucagon-like peptide-1 plays a physiological role in satiety. Endocrinology 2009; 150:1680-1687.
22. Vahl TP, Drazen DL, Seeley RJ, et al. Meal-anticipatory glucagon-like peptide-1 secretion in rats. Endocrinology 2010; 151:569-575.
23. Abbott CR, Monteiro M, Small CJ, et al. The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res 2005; 1044:127-131.
24. Baumgartner I, Pacheco-Lopez G, Ruttimann EB, et al. Hepatic-portal vein infusions of GLP-1 reduce meal size and increase c-Fos expression in the NTS, AP, and CeA in rats. J Neuroendocrinol 2010; 22:557-563.
25. Kim DH, D'Alessio DA, Woods SC, Seeley RJ. The effects of GLP-1 infusion in the hepatic portal region on food intake. Regul Pept 2009; 155 (1-3): 110-114.
26. Sandoval DA, Bagnol D, Woods SC, et al. Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake. Diabetes 2008; 57:2046-2054.
27. Meeran K, O'Shea D, Edwards CM, et al. Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat. Endocrinology 1999; 140:244-250.
28. Woods SC, D'Alessio DA. Central control of body weight and appetite. J Clin Endocrinol Metab 2008; 93 (11 Suppl 1):S37-S50.
29. Rosenstock J, Klaff LJ, Schwartz S, et al. Effects of exenatide and lifestyle modification on body weight and glucose tolerance in obese subjects with and without prediabetes. Diabetes Care 2010; 33:1173-1175.
30. Beckman LM, Beckman TR, Earthman CP. Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass procedure: a review. J Am Diet Assoc 2010; 110:571-584.
31. Castaneda TR, Tong J, Datta R, et al. Ghrelin in the regulation of body weight and metabolism. Front Neuroendocrinol 2010; 31:44-60.
32. Kamegai J, Tamura H, Shimizu T, et al. Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats. Diabetes 2001; 50:2438-2443.
33. Romero A, Kirchner H, Heppner K, et al. GOAT-the master switch for the ghrelin system? Eur J Endocrinol 2010; 0: EJE-10-0099.
34. Kirchner H, Gutierrez JA, Solenberg PJ, et al. GOAT links dietary lipids with the endocrine control of energy balance. Nat Med 2009; 15:741-745.
35. Lutz TA. The role of amylin in the control of energy homeostasis. Am J Physiol Regul Integr Comp Physiol 2010; 298:R1475-R1484.
36. Potes CS, Lutz TA. Brainstem mechanisms of amylin-induced anorexia. Physiol Behav 2010.
37. Potes CS, Lutz TA, Riediger T. Identification of central projections from amylin-activated neurons to the lateral hypothalamus. Brain Res 2010; 1334:31-44.
38. Dunican KC, Adams NM, Desilets AR. The role of pramlintide for weight loss. Ann Pharmacother 2010; 44:538-545.
39. Batterham RL, Cowley MA, Small CJ, et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 2002; 418:650-654.
40. De Kloet AD, Krause EG, Woods SC. The Renin Angiotensin System and the metabolic syndrome. Physiol Behav 2010.
41. De Kloet AD, Krause EG, Kim DH, et al. The effect of angiotensin- converting enzyme inhibition using captopril on energy balance and glucose home ostasis. Endocrinology 2009; 150:4114-4123.
42. Porter JP, Potratz KR. Effect of intracerebroventricular angiotensin II on body weight and food intake in adult rats. Am J Physiol Regul Integr Comp Physiol 2004; 287:R422-R428.
43. Berthoud HR. Interactions between the 'cognitive' and 'metabolic' brain in the control of food intake. Physiol Behav 2007; 91:486-498.
44. Levin BE, Routh VH, Kang L, et al. Neuronal glucosensing: what do we know after 50 years? Diabetes 2004; 53:2521-2528.
45. Lam TK, Pocai A, Gutierrez-Juarez R, et al. Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis. Nat Med 2005; 11:320-327.
46. Cota D, Proulx K, Smith KA, et al. Hypothalamic mTOR signaling regulates food intake. Science 2006; 312:927-930.
47. Minokoshi Y, Alquier T, Furukawa N, et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 2004; 428:569-574.
48. Leinninger GM, Jo YH, Leshan RL, et al. Leptin acts via leptin receptor-expressing lateral hypothalamic neurons to modulate the mesolimbic dopamine system and suppress feeding. Cell Metab 2009; 10:89-98.
49. Hayes MR, Skibicka KP, Leichner TM, et al. Endogenous leptin signaling in the caudal nucleus tractus solitarius and area postrema is required for energy balance regulation. Cell Metab 2010; 11:77-83.
50. Hayes MR, Skibicka KP, Bence KK, Grill HJ. Dorsal hindbrain 5'-adenosine monophosphate-activated protein kinase as an intracellular mediator of energy balance. Endocrinology 2009; 150:2175-2182.
51. Thammacharoen S, Lutz TA, Geary N, Asarian L. Hindbrain administration of estradiol inhibits feeding and activates estrogen receptor-alpha-expressing cells in the nucleus tractus solitarius of ovariectomized rats. Endocrinology 2008; 149:1609-1617.
52. Miselis RR. The efferent projections of the subfornical organ of the rat: a circumventricular organ within a neural network subserving water balance. Brain Res 1981; 230 (1-2):1-23.
53. Smith PM, Chambers AP, Price CJ, et al. The subfornical organ: a central nervous system site for actions of circulating leptin. Am J Physiol Regul Integr Comp Physiol 2009; 296:R512-R520.
54. Smith PM, Rozanski G, Ferguson AV. Acute electrical stimulation of the subfornical organ induces feeding in satiated rats. Physiol Behav 2010; 99:534-537.
55. Weintraub M, Hasday JD, Mushlin AI, Lockwood DH. A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination. Arch Intern Med 1984; 144:1143-1148.
56. Day JW, Ottaway N, Patterson JT, et al. A new glucagon and GLP-1 coagonist eliminates obesity in rodents. Nat Chem Biol 2009; 5:749-757.
57. Turek VF, Trevaskis JL, Levin BE, et al. Mechanisms of amylin/leptin synergy in rodent models. Endocrinology 2010; 151:143-152.
58. Stefater MA, Perez-Tilve D, Chambers AP, et al. Sleeve gastrectomy induces loss of weight and fat mass in obese rats, but does not affect leptin sensitivity. Gastroenterology 2010; 138:2426-2436.
59. Shin AC, Zheng H,Townsend RL, et al. Meal-induced hormone responses in a rat model of Roux-en-Y gastric bypass surgery. Endocrinology 2010; 151:1588-1597.
60. Korner J, Inabnet W, Febres G, et al. Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass. Int J Obes (Lond) 2009; 33:786-795.